Interestingly, recent studies have revealed similarities between human breast cancer (HBC) and CMTs in several areas, such as estrogen receptors and p53, suggesting that CMTs are an appropriate model for studying HBC [21–24]. This evidence concerns the gene ESR1 and breast carcinoma.